Hepatitis C Infection - Novelos Therapeutics, Inc. Gets Green Light From FDA For Phase 3 Development In Lung Cancer

Novelos Therapeutics, Inc. Gets Green Light From FDA For Phase 3 Development In Lung Cancer
BioSpace - cancer and our second compound, NOV-205, targeting

(PRN) - Three Rivers Pharmaceuticals Announces FDA Final Approval of Ribasphere(R) (ribavirin, USP) Tablets 60
Bolsamania - Three Rivers Pharmaceuticals Announces FDA Final Approval of Ribasphere(R) (ribavirin, USP) Tablets 600mg, 400mg and 200mg for the Treatment of

MIGENIX Reports Second Quarter Fiscal 2006 Results
PR Newswire - MX-3253 (treatment of

Do Specific Antiretrovirals Increase the Risk of Therapy Discontinuation by HIV-HCV Coinfected Patients Due to
HIV and Hepatitis.com - HIV-HCV Coinfected Patients Receive Treatment for

Liver Cancer,
Grand Junction Daily Sentinel - News) -- Scientists have long noted a link between

MIGENIX Reports Second Quarter Results
BC Technology - MX-3253 (treatment of